Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.


TSX:CPH - Post by User

Bullboard Posts
Comment by smush74on Sep 30, 2015 12:41pm
70 Views
Post# 24149591

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Caution

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Caution
lets try this one last time, no need for huge font. There was and is no fraud PERIOD they made a deal that would pay off in two years. (you were all happy) What they paid for was what they, the market and their advisors thought was fair value. (what would you pay?) in that they got a sales team (again you praised the move)

Then they missed their targets again last quarter and suddenly you got all hostile with accusations of fraud and theft. Tell the board in specific terms, be precise exactly the theft and fraud that occured. If your only response to the question is what you have been whining about in salaries and restating the question what I would pay for. Then don't bother wasting my time I want specifics.

You then accuse the CFO of insider selling, when you were shown that he actually bought, you then down played it based on his salary that it was nothing. By that logic had he sold the same amount it holds the same value, nothing.

Then you came out with your dooms day predictions that global economy and markets were going to crash. If that is the case then why should Cipher not feel the same pain as all the other global players?

If you are going to answer these questions by replying to them as more questions, like I said don't waste my time. I want specific answers, numbers, not what ifs and I don't care about VW.

If you can't handle market conditions us/downs buy GIC's and don't clutter the board with what you have been crying about for weeks now.
Bullboard Posts